Skip to content
value.today

Medventive Inc.

Total raised
$24 M
3 rounds on record
Latest round
$12 M
Sep 2011
First round on record
Jun 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medventive Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2011$12 MNo. 3$10 to $50 million

Medventive Inc.: Raise no. 3, Sep 2011

Investors in this round

11 investors had bought by the notice of Oct 21, 2011: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
$11,577
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Niloff · Director, Executive Officer · Chief Technology Officer
  • Mark Collins · Executive Officer · Chief Financial Officer, Treasurer and Secretary
  • Nancy Brown · Executive Officer, Director · Chief Growth Officer
  • Nancy Ham · Executive Officer, Director · President and Chief Executive Officer
  • Charles Baker · Director
  • Enrico Petrillo · Director
  • Mark Levine · Director
  • Peter Grua · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series D Preferred Stock”

Signed by Mark Collins, Chief Financial Officer, Treasurer and Secretary. Source: SEC Form D, newest notice filed Oct 21, 2011. Read the notice at the SEC.

equitySEC
May 2011$2 MNo. 2Under $2 million

Medventive Inc.: Raise no. 2, May 2011

Investors in this round

9 investors had bought by the notice of May 27, 2011: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$3,473
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Collins · Executive Officer · Chief Financial Officer, Vice President, Treasurer and Secretary
  • Nancy Ham · Executive Officer, Director, Promoter · President and Chief Executive Officer
  • Enrico Petrillo · Director
  • Jonathan Niloff · Director
  • Mark Levine · Director
  • Nancy Brown · Director
  • Peter Grua · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Convertible Promissory Notes and Warrants to purchase Series C Convertible Preferred Stock”

Signed by Mark Collins, Chief Financial Officer. Source: SEC Form D, newest notice filed May 27, 2011. Read the notice at the SEC.

debt, optionsSEC
Jun 2009$10 MNo. 1$10 to $50 million

Medventive Inc.: Raise no. 1, Jun 2009

Investors in this round

9 investors had bought by the notice of Feb 18, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Niloff · Executive Officer, Director
  • Mark Collins · Executive Officer
  • Nancy Ham · Executive Officer, Director
  • Enrico Petrillo · Director
  • Mark J. Levine · Director
  • Peter Gura · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Collins, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Feb 18, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medventive Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2011).

    SEC Form D · Oct 2011

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2011

That is all the official record says: Medventive Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Medventive Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medventive Inc.
NameRoleNamed in
Jonathan NiloffChief Technology OfficerOct 2011
Mark CollinsChief Financial Officer, Treasurer and SecretaryOct 2011
Nancy BrownChief Growth OfficerOct 2011
Nancy HamPresident and Chief Executive OfficerOct 2011
Charles BakerDirectorOct 2011
Enrico PetrilloDirectorOct 2011
Jonathan NiloffChief Technology OfficerOct 2011
Mark LevineDirectorOct 2011
Nancy BrownChief Growth OfficerOct 2011
Nancy HamPresident and Chief Executive OfficerOct 2011
Peter GruaDirectorOct 2011
Mark J. LevineDirectorFeb 2010
Peter GuraDirectorFeb 2010
William R. CowenDirectorJul 2009
Nancy HamPresident and Chief Executive OfficerMay 2011